Abstract 1041: Targeted inhibition of c-MET, Axl and DDR signaling pathways by merestinib enhances gemcitabine/<i>nab</i>-paclitaxel standard chemotherapy activity in pancreatic cancer models

Authors: Eda Shi, Margaret A. Schwarz, Md Sazzad Hassan, Urs von Holzen, Roderich E. Schwarz, Niranjan Awasthi

Published: 2021-07-01

DOI: 10.1158/1538-7445.am2021-1041

Source: Full article